Introduction: Contrast-induced acute kidney injury (CI-AKI) is a frequent complication of percutaneous coronary interventions (PCI). Various groups have developed and validated risk scores for CI-AKI. Although the majority of these risk scores achieve an adequate accuracy, their usability in clinical practice is limited and greatly debated. Objective: With the present study, we aimed to prospectively assess the diagnostic performance of recently published CI-AKI risk scores (up to 2018) in a cohort of patients undergoing PCI. Methods: We enrolled 1,247 consecutive patients (80% men, mean age 62 ± 10 years) treated with elective or urgent PCI. For each patient, we calculated the individual CI-AKI risk score based on 17 different risk models. CI-AKI was defined as an increase of ≥25% (liberal) or ≥0.5 mg/dL (strict) in pre-PCI serum creatinine 48 h after PCI. Results: CI-AKI definition and, therefore, CI-AKI incidence have a significant impact on risk model performance (median negative predictive value increased from 85 to 99%; median c-statistic increased from 0.516 to 0.603 using more strict definition criteria). All of the 17 published models were characterized by a weak-to-moderate discriminating ability mainly based on the identification of “true-negative” cases (median positive predictive value 19% with liberal criterion and 3% with strict criterion). In none of the models, c-statistic was >0.800 with either CI-AKI definition. Novel, different combinations of the >35 independent variables used in the published models either by down- or by up-scaling did not result in significant improvement in predictive performance. Conclusions: The predictive ability of all models was similar and only modest, derived mainly by identifying true-negative cases. A new approach is probably needed by adding novel markers or periprocedural characteristics.

1.
Azzalini
L
,
Candilio
L
,
McCullough
PA
,
Colombo
A
.
Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature
.
Can J Cardiol
.
2017
Oct
;
33
(
10
):
1225
8
.
[PubMed]
0828-282X
2.
Tsai
TT
,
Patel
UD
,
Chang
TI
,
Kennedy
KF
,
Masoudi
FA
,
Matheny
ME
, et al.
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry
.
JACC Cardiovasc Interv
.
2014
Jan
;
7
(
1
):
1
9
.
[PubMed]
1936-8798
3.
Chalikias
G
,
Drosos
I
,
Tziakas
DN
.
Contrast-Induced Acute Kidney Injury: an Update
.
Cardiovasc Drugs Ther
.
2016
Apr
;
30
(
2
):
215
28
.
[PubMed]
0920-3206
4.
Allen
DW
,
Ma
B
,
Leung
KC
,
Graham
MM
,
Pannu
N
,
Traboulsi
M
, et al.
Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis
.
Can J Cardiol
.
2017
Jun
;
33
(
6
):
724
36
.
[PubMed]
0828-282X
5.
Silver
SA
,
Shah
PM
,
Chertow
GM
,
Harel
S
,
Wald
R
,
Harel
Z
.
Risk prediction models for contrast induced nephropathy: systematic review
.
BMJ
.
2015
Aug
;
351
:
h4395
.
[PubMed]
0959-8138
6.
Neumann
FJ
,
Sousa-Uva
M
,
Ahlsson
A
,
Alfonso
F
,
Banning
AP
,
Benedetto
U
, et al.;
ESC Scientific Document Group
.
2018 ESC/EACTS Guidelines on myocardial revascularization
.
Eur Heart J
.
2019
Jan
;
40
(
2
):
87
165
.
[PubMed]
0195-668X
7.
McCullough
PA
.
Contrast-induced acute kidney injury
.
J Am Coll Cardiol
.
2008
Apr
;
51
(
15
):
1419
28
.
[PubMed]
0735-1097
8.
Bartholomew
BA
,
Harjai
KJ
,
Dukkipati
S
,
Boura
JA
,
Yerkey
MW
,
Glazier
S
, et al.
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
.
Am J Cardiol
.
2004
Jun
;
93
(
12
):
1515
9
.
[PubMed]
0002-9149
9.
Marenzi
G
,
Lauri
G
,
Assanelli
E
,
Campodonico
J
,
De Metrio
M
,
Marana
I
, et al.
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
.
J Am Coll Cardiol
.
2004
Nov
;
44
(
9
):
1780
5
.
[PubMed]
0735-1097
10.
Mehran
R
,
Aymong
ED
,
Nikolsky
E
,
Lasic
Z
,
Iakovou
I
,
Fahy
M
, et al.
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
.
J Am Coll Cardiol
.
2004
Oct
;
44
(
7
):
1393
9
.
[PubMed]
0735-1097
11.
Ghani
AA
,
Tohamy
KY
.
Risk score for contrast induced nephropathy following percutaneous coronary intervention
.
Saudi J Kidney Dis Transpl
.
2009
Mar
;
20
(
2
):
240
5
.
[PubMed]
1319-2442
12.
Maioli
M
,
Toso
A
,
Gallopin
M
,
Leoncini
M
,
Tedeschi
D
,
Micheletti
C
, et al.
Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention
.
J Cardiovasc Med (Hagerstown)
.
2010
Jun
;
11
(
6
):
444
9
.
[PubMed]
1558-2027
13.
Fu
N
,
Li
X
,
Yang
S
,
Chen
Y
,
Li
Q
,
Jin
D
, et al.
Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention
.
Angiology
.
2013
Apr
;
64
(
3
):
188
94
.
[PubMed]
0003-3197
14.
Gurm
HS
,
Seth
M
,
Kooiman
J
,
Share
D
.
A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention
.
J Am Coll Cardiol
.
2013
Jun
;
61
(
22
):
2242
8
.
[PubMed]
0735-1097
15.
Tziakas
D
,
Chalikias
G
,
Stakos
D
,
Apostolakis
S
,
Adina
T
,
Kikas
P
, et al.
Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice
.
Int J Cardiol
.
2013
Feb
;
163
(
1
):
46
55
.
[PubMed]
0167-5273
16.
Chen
YL
,
Fu
NK
,
Xu
J
,
Yang
SC
,
Li
S
,
Liu
YY
, et al.
A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention
.
Catheter Cardiovasc Interv
.
2014
Jan
;
83
(
1
):
E8
16
.
[PubMed]
1522-1946
17.
Victor
SM
,
Gnanaraj
A
,
S
V
,
Deshmukh
R
,
Kandasamy
M
,
Janakiraman
E
, et al.
Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention
.
Indian Heart J
.
2014
Sep-Oct
;
66
(
5
):
517
24
.
[PubMed]
0019-4832
18.
Gao
YM
,
Li
D
,
Cheng
H
,
Chen
YP
.
Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients
.
Clin Exp Nephrol
.
2014
Dec
;
18
(
6
):
892
8
.
[PubMed]
1342-1751
19.
Liu
Y
,
Liu
YH
,
Chen
JY
,
Tan
N
,
Zhou
YL
,
Li
HL
, et al.
A simple pre-procedural risk score for contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention
.
Int J Cardiol
.
2015
Feb
;
180
:
69
71
.
[PubMed]
0167-5273
20.
Brown
JR
,
MacKenzie
TA
,
Maddox
TM
,
Fly
J
,
Tsai
TT
,
Plomondon
ME
, et al.
Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation
.
J Am Heart Assoc
.
2015
Dec
;
4
(
12
):
e002136
.
[PubMed]
2047-9980
21.
Caspi
O
,
Habib
M
,
Cohen
Y
,
Kerner
A
,
Roguin
A
,
Abergel
E
, et al.
Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
J Am Heart Assoc
.
2017
Jun
;
6
(
6
):
e005715
.
[PubMed]
2047-9980
22.
Andò
G
,
Morabito
G
,
de Gregorio
C
,
Trio
O
,
Saporito
F
,
Oreto
G
.
The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention
.
Int J Cardiol
.
2013
Oct
;
168
(
4
):
4386
7
.
[PubMed]
0167-5273
23.
McCullough
PA
,
Wolyn
R
,
Rocher
LL
,
Levin
RN
,
O’Neill
WW
.
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality
.
Am J Med
.
1997
Nov
;
103
(
5
):
368
75
.
[PubMed]
0002-9343
24.
Wilson
T
,
Quan
S
,
Cheema
K
,
Zarnke
K
,
Quinn
R
,
de Koning
L
, et al.
Risk prediction models for acute kidney injury following major noncardiac surgery: systematic review
.
Nephrol Dial Transplant
.
2016
Feb
;
31
(
2
):
231
40
.
[PubMed]
1460-2385
25.
Briguori
C
,
Quintavalle
C
,
Donnarumma
E
,
Condorelli
G
.
Novel biomarkers for contrast-induced acute kidney injury
.
BioMed Res Int
.
2014
;
2014
:
568738
.
[PubMed]
2314-6133
26.
Chalikias
G
,
Drosos
I
,
Tziakas
DN
.
Prevention of Contrast-Induced Acute Kidney Injury: an Update
.
Cardiovasc Drugs Ther
.
2016
Oct
;
30
(
5
):
515
24
.
[PubMed]
0920-3206
27.
Holzscheiter
L
,
Beck
C
,
Rutz
S
,
Manuilova
E
,
Domke
I
,
Guder
WG
, et al.
NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction
.
Clin Chem Lab Med
.
2014
Apr
;
52
(
4
):
537
46
.
[PubMed]
1434-6621
28.
Okusa
MD
,
Jaber
BL
,
Doran
P
,
Duranteau
J
,
Yang
L
,
Murray
PT
, et al.
Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes
.
Contrib Nephrol
.
2013
;
182
:
65
81
.
[PubMed]
0302-5144
29.
Licurse
A
,
Kim
MC
,
Dziura
J
,
Forman
HP
,
Formica
RN
,
Makarov
DV
, et al.
Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework
.
Arch Intern Med
.
2010
Nov
;
170
(
21
):
1900
7
.
[PubMed]
0003-9926
30.
Marenzi
G
,
Cosentino
N
,
Bartorelli
AL
.
Acute kidney injury in patients with acute coronary syndromes
.
Heart
.
2015
Nov
;
101
(
22
):
1778
85
.
[PubMed]
1355-6037
31.
Chawla
LS
,
Bellomo
R
,
Bihorac
A
,
Goldstein
SL
,
Siew
ED
,
Bagshaw
SM
, et al.;
Acute Disease Quality Initiative Workgroup 16.
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
.
Nat Rev Nephrol
.
2017
Apr
;
13
(
4
):
241
57
.
[PubMed]
1759-5061
32.
Chalikias
G
,
Serif
L
,
Kikas
P
,
Thomaidis
A
,
Stakos
D
,
Makrygiannis
D
, et al.
Long-term impact of acute kidney injury on prognosis in patients with acute myocardial infarction
.
Int J Cardiol
.
2019
May
;
283
:
48
54
.
[PubMed]
0167-5273
33.
Stolker
JM
,
McCullough
PA
,
Rao
S
,
Inzucchi
SE
,
Spertus
JA
,
Maddox
TM
, et al.
Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography
.
J Am Coll Cardiol
.
2010
Apr
;
55
(
14
):
1433
40
.
[PubMed]
0735-1097
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.